Emerson Electric Co.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Surendralal Lanca Karsanbhai
- Full Time Employees
- 71,000
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Address
- 8027 Forsyth Boulevard Saint Louis MO United States of America 63105
- IPO Date
- Jun 1, 1972
- CIK
- 0000032604
- Website
- emerson.com
- Similar Companies
- Business
- Emerson Electric Co. (NYSE: EMR) is a global technology and engineering firm that provides automation solutions, process control systems, and industrial software to essential industries including oil and gas, chemicals, power generation, life sciences, and water treatment. The company operates primarily through its Automation Solutions segment, which offers DeltaV control systems, measurement and analytical instrumentation, valves and actuators, discrete automation technologies, safety and productivity solutions, control systems and software, as well as test and measurement equipment; these solutions integrate advanced sensing, analytics, artificial intelligence, machine learning, edge computing, and the Plantweb Digital Ecosystem for predictive maintenance, remote monitoring, and operational optimization. Its legacy Commercial & Residential Solutions, largely divested, previously included climate technologies such as heating, ventilation, air conditioning systems, tools, and compressors. Founded in 1890 and headquartered in St. Louis, Missouri, Emerson conducts operations worldwide across process industries, discrete and hybrid manufacturing, and high-growth verticals like LNG, semiconductors, and aerospace & defense. In recent strategic developments, Emerson completed the acquisition of all remaining outstanding shares of AspenTech in March 2025 for $265 per share, enhancing its industrial software capabilities in process optimization and asset management following its initial 55% stake in 2022; this move strengthens software-defined automation synergies in oil and gas, chemicals, and pharmaceuticals. The company also acquired Flexim in 2023 to expand clamp-on ultrasonic flow measurement for liquids, gases, and steam, and Afag for electric linear motion and factory automation, bolstering its discrete and hybrid market presence. Additionally, Emerson sold its majority stake in Climate Technologies (rebranded Copeland) to Blackstone in 2023 and its remaining interest in 2024, alongside divesting the Safety & Productivity segment and completing the $8.2 billion acquisition of National Instruments (NI) in 2023 to advance test and measurement automation; these actions complete a portfolio transformation focused on high-growth, software-enabled technologies. In November 2025, Emerson outlined 2028 financial targets emphasizing organic growth from innovation in power, life sciences, and semiconductors, with plans to return $10 billion to shareholders through repurchases and dividends.
Emerson Gears Up to Post Q3 Earnings: Here's What to Expect
Insights Into Emerson Electric (EMR) Q3: Wall Street Projections for Key Metrics
Is Emerson Electric (EMR) a Buy as Wall Street Analysts Look Optimistic?
Emerson Electric (EMR) Exceeds Market Returns: Some Facts to Consider
Eaton vs. Emerson: Which Electrification Stock Is the Better Buy?
Emerson Electric (EMR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Emerson Advances AI Across Software Portfolio, Accelerating Test Productivity by Up to 50 Percent
Emerson Expands Ovation AI Portfolio with New Intelligent Agents
5 Dividend Kings Have Raised Their Dividends for 70 Years: You May Not Know Any of Them
Missed Out on the AI Bull Market? These Industrial Stocks Might Still Be Screaming Buys.
Emerson Electric Co. (EMR) Is a Trending Stock: Facts to Know Before Betting on It
Emerson Electric (EMR) Declines More Than Market: Some Information for Investors
Emerson Automates Refinery Scheduling to Improve Margins, Respond Faster to Market Volatility
Emerson Schedules Third Quarter 2026 Earnings Release and Conference Call
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treat
Emerson Electric (EMR) Declines More Than Market: Some Information for Investors
Brokers Suggest Investing in Emerson Electric (EMR): Read This Before Placing a Bet
Investors Heavily Search Emerson Electric Co. (EMR): Here is What You Need to Know
Emerson Electric (EMR) Dips More Than Broader Market: What You Should Know